Isolated coronary artery bypass graft combined with bone marrow mononuclear cells delivered through a graft vessel for patients with previous myocardial infarction and chronic heart failure: a single-center, randomized, double-blind, placebo-controlled clinical trial.
暂无分享,去创建一个
Shengshou Hu | Xin Yuan | Jun Li | Zhe Zheng | Xin Wang | Shihua Zhao | Minjie Lu | Yun-hu Song | F. Duan | Sheng Liu | Xiaoling Zhang | Wei Wang | Ke-ming Yang | Hao Zhang | W. Feng | Zuoxiang He | Li-huan Li | Rui Shen | Xue-wen Liu
[1] L. Hsu,et al. Human bone marrow-derived adult stem cells for post-myocardial infarction cardiac repair: current status and future directions. , 2009, Singapore medical journal.
[2] A. Zeiher,et al. Intracoronary infusion of bone marrow‐derived mononuclear cells abrogates adverse left ventricular remodelling post‐acute myocardial infarction: insights from the reinfusion of enriched progenitor cells and infarct remodelling in acute myocardial infarction (REPAIR‐AMI) trial , 2009, European journal of heart failure.
[3] H. Zhang,et al. Role of cardiopulmonary bypass and arrested heart status in the early cell distribution after intracoronary infusion of bone marrow stromal cells. , 2009, The Journal of surgical research.
[4] A. Ganser,et al. Bone marrow cells are a rich source of growth factors and cytokines: implications for cell therapy trials after myocardial infarction. , 2008, European heart journal.
[5] Qiang Zhao,et al. Randomized study of mononuclear bone marrow cell transplantation in patients with coronary surgery. , 2008, The Annals of thoracic surgery.
[6] S. Brunskill,et al. Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review. , 2008, European heart journal.
[7] J. Légaré,et al. Revascularization for ischaemic cardiomyopathy , 2008, Current opinion in cardiology.
[8] Sheng-Shou Hu,et al. Injection of bone marrow mesenchymal stem cells in the borderline area of infarcted myocardium: heart status and cell distribution. , 2007, The Journal of thoracic and cardiovascular surgery.
[9] Gustav Steinhoff,et al. Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies. , 2007, The Journal of thoracic and cardiovascular surgery.
[10] J. Ornato,et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). , 2004, Circulation.
[11] Bernd Hertenstein,et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial , 2004, The Lancet.
[12] James T. Willerson,et al. Transendocardial, Autologous Bone Marrow Cell Transplantation for Severe, Chronic Ischemic Heart Failure , 2003, Circulation.
[13] P. Wernet,et al. [Intracoronary, human autologous stem cell transplantation for myocardial regeneration following myocardial infarction]. , 2001, Deutsche medizinische Wochenschrift.
[14] N. Gattermann,et al. Intrakoronare, humane autologe Stammzelltransplantation zur Myokardregeneration nach Herzinfarkt , 2001 .
[15] W. J. van der Giessen,et al. Stem cell therapy for chronic heart failure. , 2009, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.